AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34511166 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation treatment
Number of subjects: 60
Study 35213366 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART4MD tablet application
Number of subjects: 345
Study 35213366 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 345
Study 35213366 — intervention group
Group type: COMPARATOR
Intervention: Combined (PwMCI and informal caregivers)
Number of subjects: 345
Study 32539753 — intervention group
Group type: EXPERIMENTAL
Intervention: Variable Resistance Training (VRT)
Number of subjects: 36
Study 32539753 — intervention group
Group type: EXPERIMENTAL
Intervention: Constant Resistance Training (CRT)
Number of subjects: 36
Study 32539753 — intervention group
Group type: COMPARATOR
Intervention: Control (Con)
Number of subjects: 36
Study 35745107 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed lignan supplementation (secoisolariciresinol diglucoside; SDG)
Number of subjects: 42
Study 35745107 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 35770588 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga ocular exercise (20 minutes) followed by active Acu-TENS over bilateral BL 61 and BL 62 acupoints (20 minutes)
Number of subjects: 80
Study 35770588 — intervention group
Group type: COMPARATOR
Intervention: Placebo Acu-TENS (20 minutes) following the same yoga ocular exercise protocol
Number of subjects: 80
Study 32710457 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype-guided warfarin anticoagulation
Number of subjects: 507
Study 32710457 — intervention group
Group type: COMPARATOR
Intervention: Control group (clinical information only)
Number of subjects: 507
Study 34275457 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention including systematic medication review
Number of subjects: 107
Study 34275457 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 107
Study 34246233 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers and Babies intervention
Number of subjects: 738
Study 34246233 — intervention group
Group type: COMPARATOR
Intervention: Control group (home visiting programs)
Number of subjects: 738
Study 32030504 — intervention group
Group type: EXPERIMENTAL
Intervention: ACL-deficient group
Number of subjects: 2344
Study 32030504 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2344
Study 35048891 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological treatment (seven group sessions of transdiagnostic cognitive-behavioural therapy)
Number of subjects: 0
Study 35048891 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 0
Study 35048891 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological treatment
Number of subjects: 0
Study 33038087 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin-loaded polyethylene glycol microspheres (DEM-TACE)
Number of subjects: 60
Study 33038087 — intervention group
Group type: COMPARATOR
Intervention: Conventional TACE (c-TACE)
Number of subjects: 60
Study 33038087 — intervention group
Group type: EXPERIMENTAL
Intervention: Both DEM-TACE and c-TACE
Number of subjects: 60
Study 33038087 — intervention group
Group type: COMPARATOR
Intervention: c-TACE
Number of subjects: 60
Study 33038087 — intervention group
Group type: EXPERIMENTAL
Intervention: DEM-TACE
Number of subjects: 60
Study 32390736 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Stretching (DS)
Number of subjects: 40
Study 32390736 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Stretching followed by Vibration Foam Rolling (DS + VFR)
Number of subjects: 40
Study 35366217 — intervention group
Group type: EXPERIMENTAL
Intervention: Study group (children at risk of SDB)
Number of subjects: 131
Study 35366217 — intervention group
Group type: COMPARATOR
Intervention: Control group (children with negative PSQ results)
Number of subjects: 131
Study 34222793 — intervention group
Group type: EXPERIMENTAL
Intervention: Shamiri-Digital (focused on gratitude, growth mindsets and values)
Number of subjects: 926
Study 34222793 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital-CBT (focused on behavioural activation, cognitive restructuring and problem solving)
Number of subjects: 926
Study 34222793 — intervention group
Group type: COMPARATOR
Intervention: Study-skills control condition (focused on note-taking and essay writing skills)
Number of subjects: 926
Study 34915576 — intervention group
Group type: EXPERIMENTAL
Intervention: sarilumab 150 mg
Number of subjects: 334
Study 34915576 — intervention group
Group type: EXPERIMENTAL
Intervention: sarilumab 200 mg
Number of subjects: 334
Study 34915576 — intervention group
Group type: EXPERIMENTAL
Intervention: sarilumab (150 mg or 200 mg)
Number of subjects: 334
Study 33883301 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular training (NM)
Number of subjects: 22
Study 33883301 — intervention group
Group type: COMPARATOR
Intervention: Conventional training (CONV)
Number of subjects: 22
Study 36336743 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized verapamil (10 mg, 4 ampoules of 2.5 mg/ml verapamil solutions)
Number of subjects: 30
Study 36336743 — intervention group
Group type: COMPARATOR
Intervention: Nebulized distilled water (placebo)
Number of subjects: 30
Study 36336743 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized verapamil (10 mg)
Number of subjects: 30
Study 33773221 — intervention group
Group type: EXPERIMENTAL
Intervention: Productive failure
Number of subjects: 344
Study 33773221 — intervention group
Group type: COMPARATOR
Intervention: Direct instruction
Number of subjects: 344
Study 33205810 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 44
Study 33205810 — intervention group
Group type: COMPARATOR
Intervention: Gliclazide
Number of subjects: 44
Study 35452752 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT + GDP + chidamide (chidamide group)
Number of subjects: 74
Study 35452752 — intervention group
Group type: COMPARATOR
Intervention: IMRT + GDP (control group)
Number of subjects: 74
Study 34491323 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 7213
Study 34491323 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 7213
Study 34112703 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperinflammatory subphenotype
Number of subjects: 568
Study 34112703 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoinflammatory subphenotype
Number of subjects: 568
Study 33540841 — intervention group
Group type: EXPERIMENTAL
Intervention: 900 mg/day of polyphenol-rich supplement
Number of subjects: 72
Study 33540841 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 32508183 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care physiotherapy with app‐based supplemental exercise programme
Number of subjects: 144
Study 32508183 — intervention group
Group type: COMPARATOR
Intervention: Usual care physiotherapy
Number of subjects: 144
Study 36426355 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (Bifidobacterium Tetragenous viable Bacteria Tablets)
Number of subjects: 276
Study 36426355 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 276
Study 36426355 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 276
Study 33006656 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline FDG-PET/CT imaging with positive results and focal bone lesions (FLs) and/or extramedullary disease (EMD)
Number of subjects: 139
Study 35985981 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen Deprivation Therapy with Docetaxel
Number of subjects: 0
Study 35985981 — intervention group
Group type: COMPARATOR
Intervention: Androgen Deprivation Therapy without Docetaxel
Number of subjects: 0
Study 34085149 — intervention group
Group type: EXPERIMENTAL
Intervention: Early cannabis (EC, n = 15)
Number of subjects: 30
Study 34085149 — intervention group
Group type: COMPARATOR
Intervention: Delayed start cannabis (DC, n = 15)
Number of subjects: 30
Study 32424568 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitor group (MG)
Number of subjects: 20
Study 32424568 — intervention group
Group type: COMPARATOR
Intervention: Ocular group (OG)
Number of subjects: 20
Study 32424568 — intervention group
Group type: EXPERIMENTAL
Intervention: Preclinical data
Number of subjects: 20
Study 35113021 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboot Online combined with telephone support (n=44)
Number of subjects: 89
Study 35113021 — intervention group
Group type: COMPARATOR
Intervention: Reboot Online alone (n=45)
Number of subjects: 89
Study 34098033 — intervention group
Group type: COMPARATOR
Intervention: CCC
Number of subjects: 26810
Study 34098033 — intervention group
Group type: EXPERIMENTAL
Intervention: 30:2
Number of subjects: 26810
Study 32938444 — intervention group
Group type: COMPARATOR
Intervention: 300 mg CQ (Control)
Number of subjects: 18
Study 32938444 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg CQ and 2 gm azithromycin (CQAZ)
Number of subjects: 18
Study 32938444 — intervention group
Group type: EXPERIMENTAL
Intervention: CQAZ
Number of subjects: 18
Study 33497252 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-pelvic radiotherapy (WPRT, 68 Gy/25# to prostate, 50 Gy/25# to pelvic nodes)
Number of subjects: 224
Study 33497252 — intervention group
Group type: COMPARATOR
Intervention: Prostate-only radiotherapy (PORT, 68 Gy/25# to prostate)
Number of subjects: 224
Study 33497252 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-pelvic radiotherapy (WPRT)
Number of subjects: 224
Study 33497252 — intervention group
Group type: COMPARATOR
Intervention: Prostate-only radiotherapy (PORT)
Number of subjects: 224
Study 33186054 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg once daily
Number of subjects: 4304
Study 33186054 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4304
Study 33378671 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise
Number of subjects: 0
Study 33378671 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 0
Study 35581970 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness cognitive intervention method (MBCT)
Number of subjects: 22
Study 33759678 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplement (SUPP) - 200-mL carton of juice-based emulsion containing 3000 mg LC n-3 PUFA (1500 mg DHA and 1500 mg EPA), 8 g whey protein isolate, 400 IU vitamin D3, 150 mg resveratrol
Number of subjects: 37
Study 33759678 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplement (SUPP)
Number of subjects: 37
Study 33759678 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 37
Study 34895285 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) for 16 weeks
Number of subjects: 42
Study 34895285 — intervention group
Group type: COMPARATOR
Intervention: Written information only (Control group)
Number of subjects: 42
Study 34895285 — intervention group
Group type: EXPERIMENTAL
Intervention: Cough-suppression techniques (CST)
Number of subjects: 42
Study 35965483 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie restriction (CR)
Number of subjects: 220
Study 33722490 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided femoral punctures
Number of subjects: 1388
Study 33722490 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided radial punctures
Number of subjects: 1388
Study 33722490 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided femoral access (trainees)
Number of subjects: 1388
Study 33722490 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided radial access (trainees)
Number of subjects: 1388
Study 33722490 — intervention group
Group type: COMPARATOR
Intervention: Standard transradial access
Number of subjects: 1388
Study 32122216 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg twice daily
Number of subjects: 110
Study 32122216 — intervention group
Group type: COMPARATOR
Intervention: Prasugrel 10 mg once a day
Number of subjects: 110
Study 32122216 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 110
Study 32122216 — intervention group
Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 110
Study 34936948 — intervention group
Group type: EXPERIMENTAL
Intervention: Breads made with two different wheat evolutionary populations (Bio2, ICARDA)
Number of subjects: 12
Study 34936948 — intervention group
Group type: COMPARATOR
Intervention: Control breads (modern variety Bologna)
Number of subjects: 12
Study 32993653 — intervention group
Group type: EXPERIMENTAL
Intervention: Echium amoenum (EA) 450 mg capsules per day (three times a day) for two consecutive cycles
Number of subjects: 84
Study 32993653 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 35297731 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised Stimulation Level (RSL)
Number of subjects: 11
Study 35297731 — intervention group
Group type: COMPARATOR
Intervention: Conventional stimulation paradigm
Number of subjects: 11
Study 33028427 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed (20 g/d)
Number of subjects: 72
Study 33028427 — intervention group
Group type: COMPARATOR
Intervention: Puffed wheat (25 g/d)
Number of subjects: 72
Study 35400174 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine
Number of subjects: 84
Study 34337919 — intervention group
Group type: EXPERIMENTAL
Intervention: Left paratracheal pressure (LPP)
Number of subjects: 108
Study 34337919 — intervention group
Group type: COMPARATOR
Intervention: Cricoid pressure (CP)
Number of subjects: 108
Study 32521299 — intervention group
Group type: EXPERIMENTAL
Intervention: Buffered hypertonic seawater (BHS)
Number of subjects: 93
Study 32521299 — intervention group
Group type: COMPARATOR
Intervention: Physiological seawater (PS)
Number of subjects: 93
Study 32521299 — intervention group
Group type: EXPERIMENTAL
Intervention: Buffered hypertonic seawater (BHS) in nonECRSwNP subgroup
Number of subjects: 93
Study 32521299 — intervention group
Group type: COMPARATOR
Intervention: Physiological seawater (PS) in nonECRSwNP subgroup
Number of subjects: 93
Study 35840947 — intervention group
Group type: EXPERIMENTAL
Intervention: Information provided in the patient admission area by the same staff member (Group A)
Number of subjects: 263
Study 35840947 — intervention group
Group type: COMPARATOR
Intervention: Information provided in a separate room by another staff member (Group B)
Number of subjects: 263
Study 35840947 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 263
Study 32773268 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous and periarticular steroids (IVPAS)
Number of subjects: 46
Study 32773268 — intervention group
Group type: COMPARATOR
Intervention: Intravenous steroids only
Number of subjects: 46
Study 33923244 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 min of moderate intensity aerobic exercise (walking) (A)
Number of subjects: 8
Study 33923244 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 min of combined aerobic and resistance exercise (AR)
Number of subjects: 8
Study 33923244 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 min of combined resistance and aerobic exercise (RA)
Number of subjects: 8
Study 33923244 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 min of resistance exercise (R)
Number of subjects: 8
Study 33923244 — intervention group
Group type: COMPARATOR
Intervention: Uninterrupted sitting (CON)
Number of subjects: 8
Study 33923244 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of A and AR to RA
Number of subjects: 8
Study 33121471 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin plus Metformin (100 mg aspirin and 250 mg metformin for 8 weeks)
Number of subjects: 0
Study 33121471 — intervention group
Group type: COMPARATOR
Intervention: Aspirin plus Placebo (100 mg aspirin and placebo for 8 weeks)
Number of subjects: 0
Study 34728786 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel intraoral cooling device (ICD)
Number of subjects: 172
Study 34728786 — intervention group
Group type: COMPARATOR
Intervention: Ice cooling (IC)
Number of subjects: 172
Study 32512071 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Cd exposure in RWPE1 and PWR1E cells
Number of subjects: 3
Study 32512071 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-week Cd exposure in DU 145 cells
Number of subjects: 3
Study 32512071 — intervention group
Group type: EXPERIMENTAL
Intervention: Cd exposure in RWPE1 and PWR1E cells
Number of subjects: 3
Study 32512071 — intervention group
Group type: EXPERIMENTAL
Intervention: Erk/MAPK pathway activation
Number of subjects: 3
Study 36372695 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (Lactobacillus ruteri, 100 mg)
Number of subjects: 450
Study 36372695 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 450
Study 34601835 — intervention group
Group type: EXPERIMENTAL
Intervention: Cook balloon uterine stent placed for 37 days in Group A
Number of subjects: 98
Study 34601835 — intervention group
Group type: COMPARATOR
Intervention: Cook balloon uterine stent placed for 7 days in Group B
Number of subjects: 98
Study 32590726 — intervention group
Group type: EXPERIMENTAL
Intervention: No-reflow group (331 patients, 29.5% incidence) in the development cohort
Number of subjects: 1658
Study 32590726 — intervention group
Group type: EXPERIMENTAL
Intervention: No-reflow risk scoring system tested in validation cohort (536 patients, 30.1% incidence)
Number of subjects: 1658
Study 34379314 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 40 mg once daily in pediatric patients with body weight ≥ 40 kg
Number of subjects: 19
Study 34379314 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg once daily in pediatric patients with body weight < 40 kg and aged ≥ 2 years
Number of subjects: 19
Study 34379314 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil doses studied in pediatric population
Number of subjects: 19
Study 34379314 — intervention group
Group type: EXPERIMENTAL
Intervention: Modeling and simulation
Number of subjects: 19
Study 34379314 — intervention group
Group type: COMPARATOR
Intervention: Bosentan
Number of subjects: 19
Study 35972243 — intervention group
Group type: EXPERIMENTAL
Intervention: ICU eDischarge tool
Number of subjects: 0
Study 35972243 — intervention group
Group type: COMPARATOR
Intervention: Control (preimplementation period)
Number of subjects: 0
Study 35972243 — intervention group
Group type: COMPARATOR
Intervention: Control (nonpreventable adverse events)
Number of subjects: 0
Study 33947668 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-coordinated interdisciplinary smoking cessation intervention
Number of subjects: 690
Study 33947668 — intervention group
Group type: COMPARATOR
Intervention: Usual care plus Quitline referral
Number of subjects: 690
Study 33947668 — intervention group
Group type: EXPERIMENTAL
Intervention: Home medicines review (HMR) and home-based pulmonary rehabilitation (HomeBase) for COPD patients
Number of subjects: 690
Study 35660535 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross‐legged sitting
Number of subjects: 30
Study 35660535 — intervention group
Group type: COMPARATOR
Intervention: Sitting on a chair
Number of subjects: 30
Study 35660535 — intervention group
Group type: EXPERIMENTAL
Intervention: Side‐sitting
Number of subjects: 30
Study 34900780 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic 'Visbiome®' (n=8)
Number of subjects: 15
Study 34900780 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=7)
Number of subjects: 15
Study 33499659 — intervention group
Group type: EXPERIMENTAL
Intervention: TF-CBT with adjunctive AAT (TF-CBT+AAT)
Number of subjects: 0
Study 33499659 — intervention group
Group type: COMPARATOR
Intervention: Standard TF-CBT
Number of subjects: 0
Study 33985503 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-managed continuous monitoring
Number of subjects: 198
Study 33985503 — intervention group
Group type: COMPARATOR
Intervention: Control group (supervisory visit)
Number of subjects: 198
Study 35314880 — intervention group
Group type: EXPERIMENTAL
Intervention: DCB
Number of subjects: 132
Study 35314880 — intervention group
Group type: COMPARATOR
Intervention: POBA
Number of subjects: 132
Study 32367666 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous nerve evaluation (PNE) without fluoroscopy
Number of subjects: 74
Study 32367666 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous nerve evaluation (PNE) with fluoroscopy
Number of subjects: 74
Study 35455677 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep NMB
Number of subjects: 144
Study 35455677 — intervention group
Group type: COMPARATOR
Intervention: Moderate NMB
Number of subjects: 144
Study 34038852 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Lavage (PL) used during operation
Number of subjects: 176
Study 34038852 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PL)
Number of subjects: 176
Study 34038852 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Lavage (PL)
Number of subjects: 176
Study 33478749 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid induction (RI) with TCI of propofol effect‐site (CeCALC) 5.4μg/mL (modified Marsh model)
Number of subjects: 16
Study 33478749 — intervention group
Group type: COMPARATOR
Intervention: Slow induction (SI) with propofol infusion of 10mg/kg/hour
Number of subjects: 16
Study 33206752 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy after 3 hours of colon preparation with 10% mannitol
Number of subjects: 100
Study 33206752 — intervention group
Group type: COMPARATOR
Intervention: Colonoscopy after 6 hours of colon preparation with 10% mannitol
Number of subjects: 100
Study 33206752 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy after 3 hours of colon preparation with 10% mannitol in patients with diabetes mellitus
Number of subjects: 100
Study 36208619 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent neuromuscular warm-up program
Number of subjects: 112
Study 36208619 — intervention group
Group type: COMPARATOR
Intervention: Typical warm-up program
Number of subjects: 112
Study 33870722 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise training (RT) for 14 weeks, 3 days/week, alternating high-low-high intensity
Number of subjects: 31
Study 33870722 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline gene expression
Number of subjects: 31
Study 33870722 — intervention group
Group type: EXPERIMENTAL
Intervention: Response networks identified through WGCNA
Number of subjects: 31
Study 32271970 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg BID
Number of subjects: 0